Physician profile
Youngsook Yoon
NPI 1023004272
$1,450.64
in general payments reported to CMS, 2019-2025
18 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2021: $173 · 2022: $53.98 · 2023: $366 · 2024: $416 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.67 | 2019-2024 | Ofev |
| Intuitive Surgical, INC. | $177.19 | 2021-2024 | |
| Baxter Healthcare | $175.32 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Actelion Pharmaceuticals US, INC. | $147.85 | 2019-2024 | Opsumit, Uptravi |
| Pulmonx Corporation | $125.31 | 2021 | |
| Contego Medical, INC | $121.63 | 2024 | |
| Mallinckrodt Hospital Products INC. | $106.89 | 2023 | Acthar |
| Astrazeneca Pharmaceuticals LP | $65.02 | 2019-2025 | |
| Glaxosmithkline, LLC. | $51.42 | 2023-2025 | Trelegy Ellipta, Nucala |
| United Therapeutics Corporation | $44.68 | 2025 | Tyvaso |
| La Jolla Pharmaceutical Company | $40.34 | 2024-2025 | Giapreza, Zevtera |
| Pfizer INC. | $36.14 | 2024-2025 | |
| Insmed, INC. | $36.04 | 2025 | Brinsupri, Arikayce |
| Amgen INC. | $35.50 | 2024-2025 | Tezspire |
| Grifols USA, LLC | $29.35 | 2024 | Prolastin-C Liquid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $24.65 | 2025 | |
| Inspire Medical Systems, INC. | $22.75 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $20.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Youngsook Yoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.